Kraig Biocraft Laboratories Delivers First Shipment of Monster Silk to Warwick Mills
December 09 2013 - 6:05AM
Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) ("Company"), the
leading developer of advanced spider silk based fibers, announced
today that the Company delivered the first shipment of its Monster
Silk(TM) recombinant spider silk fiber to Warwick Mills, Inc.
("Warwick"). Warwick is a leader in the engineering and development
of advanced technical textiles and protective materials.
The shipment represents a key step in the Companies'
collaborative development initiative with Warwick, which will
target the development of advanced spider silk based textiles.
"This first shipment of Monster Silk(TM) marks a new phase for
Kraig and it demonstrates the efficacy of our research and
development program and business model," said Kraig CEO and
founder, Kim K. Thompson. "Warwick Mills is an innovator with a
strong track record of developing and weaving advanced high
strength textiles. So the delivery of this first small shipment of
recombinant spider silk to them is a very exciting milestone in the
commercialization of spider silk," concluded Thompson.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully
reporting biotechnology company is the leading developer of
genetically engineered spider silk based fiber technologies. The
Company has achieved a series of scientific breakthroughs in the
area of spider silk technology with implications for the global
textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "estimated," "hopes," "if," "develops," "researching,"
"research," "pilot," "potential," "could" or other words or phrases
of similar import. Forward looking statements include descriptions
of the Company's business strategy, outlook, objectives, plans,
intentions and goals. All such forward-looking statements are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those in forward-looking
statements.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any security.
CONTACT: Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Sep 2023 to Sep 2024